ISRCTN97879847CompletedNot Applicable
A study to determine the effect of post-infusion cooling time in the high dose 5-fluorouracil, 4-epidoxorubicin and cyclophosphamide (FEC)-regime
Medical Centre Alkmaar (Medisch Centrum Alkmaar) (The Netherlands)0 sites130 target enrollmentStarted: July 21, 2006Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 130
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- Female
Inclusion Criteria
- •1. Intravenously administered FEC-regimen with an epirubicin dose of 90 mg/m^2 or more at three-weekly intervals
- •2. Aged 18 years or more
- •3. Written informed consent
Exclusion Criteria
- •1. Baldness before the start of the study
- •2. Hematological malignancies with generalized haematogenic metastases and if in those conditions chemotherapy is given with a curative intent
- •3. Clinical signs of scalp metastases
Investigators
Similar Trials
Completed
Not Applicable
A study to determine the effect of post-infusion scalp cooling time in the high dose FEC-regimehair loss10006291alopeciaNL-OMON40042Medisch Centrum Alkmaar130
Completed
Not Applicable
A study to determine the effect of post-infusion cooling time in the high dose FEC-regimen.breast cancerFEC high chemotherapyalopeciascalp coolingNL-OMON25604S. de BieMedisch Centrum Almaars.m.de.bie@mca.nl072-5484444130
Completed
Phase 2
Title : Clinical evaluation of the effect of the combination of herbal cream containing Rosmarinus officinalis, , Malva sylvestris, Foeniculum vulgare extract and Oenothera biennis and Bitter Almond Oil for treatment of hair loos on patients with Areata AlopeciaHair loss in patients with alopecia areata.(L00-L99)(L80-L99)IRCT20220818055740N3Shahre-kord University of Medical Sciences150
Completed
Not Applicable
Research study of patients after injection of TraceIT hydrogel for the treatment of their prostate cancerCancer - ProstateProstate CancerACTRN12618000934246Genesis Cancer Care10
Completed
Not Applicable
A clinical study for evaluating the effects of P-chondroitin NHZ on knee joint symptomsJPRN-UMIN000025992Soiken Inc.40